Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer
Title:
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer
Author:
Carrato, A. Gómez, A. Escudero, P. Chaves, M. Rivera, F. Marcuello, E. González, E. Grávalos, C. Constenla, M. Manzano, J. Luis Losa, F. Maurel, J. Dueñas, R. Massuti, B. Gallego, J. Aparicio, J. Antón, A. Aranda, E.